That’s a problem for a few reasons. First, the marijuana grown there isn’t of the highest quality said Sisley. Second, it’s the only game in town, so if the lab at Ole Miss doesn’t have it, it doesn’t happen.
“For every study, we have to buy from Mississippi,” Sisley explained. “And they’ve never had topicals, never had topicals available.”
Still, Sisley said she thinks cannabis-based topicals could have a wide variety of applications.
While issues like arthritic joint pain, soreness from past injuries and other chronic pain conditions could be alleviated, Sisley also mentioned skin conditions like acne and psoriasis.
“Again, all of these conditions, skin conditions have an inflammatory component to them,” she said.
Robinette, who has been involved with NORML and marijuana advocacy for years, said he sees topicals as a sort of bridge product between the cannabis industry and a curious public. That’s due in part to topicals not having a psychoactive effect.
“So what you find is, particularly with elderly people, you’ll find that it’s almost like their gateway drug into the world of cannabis,” he said. “Because it’s something they can just rub on.”
Sisley, who is currently involved in a case against the DEA and federal government in order to break the University of Mississippi’s monopoly on growing cannabis for research, said that she is surprised that large pharmaceutical companies haven’t pounced on the nascent cannabis-topical industry.